TREM2 protects from atherosclerosis by limiting necrotic core formationMarie Piollet, Clément Cochain, Antoine‐Emmanuel Saliba et al.|Nature Cardiovascular Research|2024Cited by 109
Beta 2 Microglobulin and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid AtherosclerosisJasmin Amighi, Oswald Wagner, Matthias Hoke et al.|Stroke|2011Cited by 84
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolismMatthias Hoke, Sabine Eichinger, Paul A. Kyrle et al.|Thrombosis and Haemostasis|2005Cited by 68
Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid AtherosclerosisMatthias Hoke, Martin Schillinger, Jasmin Amighi et al.|Stroke|2010Cited by 61
Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitusMatthias Hoke, Florian Mayer, Martin Schillinger et al.|Cardiovascular Diabetology|2019Cited by 35